Development of the model for predicting the efficacy of bevacizumab and prognosis in ovarian cancer using deep learning-based pathomics signatures.

Journal: Chinese medical journal
Published Date:

Abstract

No abstract available for this article.

Authors

Keywords

No keywords available for this article.